Expanding Service Margins While Protecting Clinical Availability
Join Genpact as they help Medtech Service leaders tackle the margin challenge by transitioning to a Predictive Triage & Guaranteed Uptime model.
Inside AdvaMed’s Standards Program: Building Consensus, Driving Innovation
Learn how AdvaMed’s standards are shaping innovation and improving regulatory efficiency across the medical technology industry.
Navigating the ACCESS & TEMPO Models: A Direct Dialogue with CMMI & FDA Leaders
Watch AdvaMed’s® exclusive member-only webinar featuring a direct dialogue with CMS Innovation Center leadership on the newly released ACCESS & TEMPO Model. Attendees will gain critical insights into model performance…
The Supreme Court Struck Down IEEPA Tariffs – What Medtech Needs To Know
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
The MedTech Conference: Call for Sessions
Call for Sessions is open — and we can’t wait to see what ideas you’ll bring forward. The conversations that change our industry start here. Apply by February 20.
Human Factors in the Digital MedTech Era: The Usability of Connected Technology
Join EPAM as they explore how robust Human Factor practices can help teams navigate usability and compliance of products in an increasingly digital landscape.
Medical Device Submissions Series: Investigational Device Exemption (IDE) Workshop
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
Medical Device Submissions Series: Premarket Approval (PMA) Workshop
Learn key PMA Submissions strategies to build a strong submissions, align with FDA expectations, and reduce delays.
Medical Device Submissions Series: 510(k) & De Novo Workshop
Join industry leaders for the in-depth 510(k) & De Novo Workshop for real-world case studies, submissions tips and best practices.
QMSR Transition: Legal and Audit Perspectives
Join Hogan Lovells experts to learn how the FDA is set to reshape the medical device regulatory landscape with the introduction of the QMSR.